• Pentoxifylline Modulates Neonatal Monocyte Hyperinflammation

  2026-05-25

  This study provides the first detailed in vitro analysis of pentoxifylline's anti-inflammatory effects on LPS-stimulated monocytes from preterm neonates, demonstrating age-dependent modulation of surface markers, cytokine production, and TLR4 signaling. Findings suggest that pentoxifylline could offer tailored immunomodulation in neonatal sepsis, though translational limits remain.

• Hoechst 33342 Nuclear Stain: Precision in Live and Fixed Cel

  2026-05-25

  APExBIO's Hoechst 33342 Solution (1 mg/mL) delivers high-fidelity nuclear labeling for both live and fixed cell workflows, making it a cornerstone for advanced senescence and mitochondrial quality studies. Its superior cell permeability and minimal cytotoxicity empower robust imaging and flow cytometry, with protocol flexibility and troubleshooting strategies tailored to demanding research environments.

• AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosid

  2026-05-24

  AICAR, a gold-standard AMPK activator, enables precise dissection of cellular energy regulation and inflammation inhibition in both in vitro and in vivo models. This guide translates cutting-edge reference research and peer-reviewed best practices into actionable workflows, troubleshooting tips, and assay optimizations for metabolic and muscle disease studies.

• One-step TUNEL FITC Kit: Precision Apoptosis Detection in Na

  2026-05-23

  Explore how the One-step TUNEL FITC Apoptosis Detection Kit advances apoptosis detection with FITC-labeled dUTP incorporation, and discover its pivotal role in unraveling nano-plastic-induced cellular damage—delivering scientific insights and protocol clarity beyond conventional guides.

• Syringin Enhances Sunitinib Efficacy in RCC via EGFR/PI3K/Ak

  2026-05-22

  This study identifies Syringin as a novel agent targeting the EGFR/PI3K/Akt pathway in renal cell carcinoma (RCC), significantly increasing the anticancer efficacy of Sunitinib. The findings suggest potential strategies to overcome Sunitinib resistance in RCC by integrating natural bioactive compounds.

• Technical Guide: Hoechst 33342/PI Double Staining Kit (K2237

  2026-05-22

  The Hoechst 33342/PI Double Staining Kit enables fluorescence-based discrimination of viable, apoptotic, and necrotic cells by assessing chromatin condensation and membrane integrity. It is intended for research workflows requiring rapid, microscopy-based cell death analysis, but should not be used for diagnostic or clinical purposes.

• CCK-8: Translational Insights in Iron Overload and Cell Inju

  2026-05-21

  Explore the mechanistic power and strategic value of Cell Counting Kit-8 (CCK-8) in addressing cell viability, proliferation, and oxidative injury in advanced translational models. This article integrates recent omics-driven findings in iron overload-induced liver injury and offers actionable guidance for researchers navigating the interface between mechanistic discovery and preclinical innovation.

• Syringin Natural Product: Mechanism and RCC Research Integra

  2026-05-21

  Syringin is a phenylpropanoid glycoside with a defined chemical structure, high purity, and documented bioactivity in renal cell carcinoma models. It demonstrates apoptosis induction and enhances sunitinib efficacy via EGFR/PI3K/Akt pathway modulation. This article reviews mechanistic evidence, workflow parameters, and critical limitations for research use.

• MLN4924: Precision NEDD8-Activating Enzyme Inhibition in Can

  2026-05-20

  MLN4924 is a highly selective NEDD8-activating enzyme inhibitor that empowers cancer researchers to dissect neddylation pathways and CRL activity with unrivaled specificity. This article details actionable experimental workflows, troubleshooting strategies, and new insights from recent studies—making MLN4924 an indispensable tool for translational oncology.

• Autophagy–Metastasis Signature Predicts CRC Prognosis and Im

  2026-05-20

  Bai et al. (2026) developed a prognostic risk signature for colorectal cancer by integrating autophagy and liver metastasis gene expression using multi-omic transcriptomic analyses. Their findings link specific gene markers to immune microenvironment shifts and potential immunotherapy resistance, informing both risk stratification and therapeutic research in oncology.

• Vemurafenib (PLX4032): Dissecting Adaptive Resistance in Mel

  2026-05-19

  Explore the scientific foundation and practical nuances of Vemurafenib (PLX4032) in melanoma research. This article uniquely unpacks adaptive resistance networks and assay design, offering advanced, evidence-based insights for cancer biology studies.

• Dual Enzyme-Responsive Zwitterionic Peptides for Cancer Sele

  2026-05-19

  This study introduces a zwitterionic peptide amphiphile designed for dual enzyme responsiveness, enabling precise cancer cell targeting via intralysosomal self-assembly. The approach demonstrates a markedly improved cancer selectivity index and highlights new directions for peptide-based cancer therapeutics.

• EdU Imaging Kits (HF594): Technical Guidance and Protocols

  2026-05-18

  EdU Imaging Kits (HF594) provide reliable, antibody-free DNA synthesis measurement for quantifying cell proliferation in S-phase, overcoming the harsh treatment and high background of BrdU protocols. This kit is best suited for fluorescence microscopy and flow cytometry proliferation assays; it should not be used in workflows requiring live-cell imaging or non-S-phase detection.

• Technical Application of Hoechst 33342/PI Double Staining Ki

  2026-05-18

  The Hoechst 33342/PI Double Staining Kit provides a direct, fluorescence-based approach for distinguishing between viable, apoptotic, and necrotic cells in basic cell biology research. It should not be used for diagnostic or clinical purposes, but is well-suited for research contexts requiring reliable chromatin condensation and membrane integrity assessment.

• DAPI Solution (1 mg/mL): Precision Nuclear Staining for Sene

  2026-05-17

  Explore the advanced use of DAPI (4',6-Diamidino-2-Phenylindole) Solution (1 mg/mL) for high-fidelity nuclear visualization in senescence and immune cell polarization research. This article provides a uniquely integrative, evidence-driven guide for assay design, grounded in recent breakthroughs on cell fate and metabolic reprogramming.

402 records 7/27 page Previous Next First page 上5页 678910 下5页 Last page